A symptom Self-rating Scale for Schizophrenia (4S): Psychometric properties, reliability and validity

References

• Overall JE, Gorham DR. Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799–912
   Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Eysenck HJ. Dimensions of personality. Routledge & Kegan Paul, London 1947
   Google Scholar
• Bowie, CR, Twamley, EW, Anderson, H, Halpern, B, Patterson, TL, Harvey, PD. Self-assessment of functional status in schizophrenia. J Psychiatr Res 2007;41:1012–8. Epub 2006; Oct 2.
   PubMed Web of Science ®Google Scholar
• Jensen J, Nilsson LL, Levander S. Neurocognitive and psychopathological correlates of self-monitoring ability in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004; 254: 312–7
   PubMedGoogle Scholar
• Rubino IA, Romeo D, Scarpellino A, Siracusano A. Clinicians’ ratings and self-reports of basic symptoms. Percept Mot Skills 2002; 95: 373–4
   PubMedGoogle Scholar
• Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, et al. Schizophrenia: Manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992; 20: 1–97
   PubMedGoogle Scholar
• Buckley PF, Wirshing DA, Bhushan P, Pierre JM, Resnick SA, Wirshing WC. Lack of insight in schizophrenia: Impact on treatment adherence. CNS Drugs 2007; 21: 129–41
   PubMed Web of Science ®Google Scholar
• Maurer Y, Dittrich A. [Comparison of psychiatrist's rating and self rating of schizoprenic patients (author's transl)]. Pharmakopsychiatrie, Neuro-Psychopharmakologie 1979; 12: 375–82
   PubMedGoogle Scholar
• Selten JP, Sijben NE, van den Bosch RJ, Omloo-Visser J, Warmerdam H. The subjective experience of negative symptoms: A self-rating scale. Comprehens Psychiatry 1993; 34: 192–7
   PubMedGoogle Scholar
• Selten JP, Wiersma D, van den Bosch RJ. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms. Comprehens Psychiatry 2000; 41: 191–6
   PubMed Web of Science ®Google Scholar
• Gallhofer B, Bauer U, Lis S, Krieger S, Gruppe H. Cognitive dysfunction in schizophrenia: Comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol 1996; 6(Suppl 2)S13–20
   PubMedGoogle Scholar
• Nilsson LL, Levandel S. Quality of life and scizophrenia: No subjective differences among four living conditions. Nord J Psychiatry 1998; 52: 277–83
   Web of Science ®Google Scholar
• Bengtsson-Tops A, Hansson L, Sandlund M, Bjarnason O, Korkeila J, Merinder L, et al. Subjective versus interviewer assessment of global quality of life among persons with schizophrenia living in the community: A Nordic multicentre study. Qual Life Res 2005; 14: 221–9
   PubMed Web of Science ®Google Scholar
• Lindstrom E, Eberhard J, Levander S. Five years follow up during antipsychotic treatment; Efficacy, safety, functional and social outcome. Acta Psychiatr Scand Suppl 2007; 435: 5–16
   Google Scholar
• Jedenius E, Lindstrom E. The development of a Self Rating Scale in Schizophrenia. XI World Congress of Psychiatry. WPA, Hamburg 1999
   Google Scholar
• Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiat Scand 1987; 334: 1–100
   Google Scholar
• Chouinard, G, Ross-Chouinard, A, Annable, L. The Extrapyramidal symptom rating scale. Can J Neurol Sci 1980;7.
   Google Scholar
• Diagnostic and statistical manual of mental disorders IVth edition. Washington, DC: APA; 1994.
   Google Scholar
• Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–76
   PubMed Web of Science ®Google Scholar
• von Knorring L, Lindstrom E. The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability. Acta Psychiatr Scand 1992; 86: 463–8
   PubMed Web of Science ®Google Scholar
• Gye W. ECDEU Assessment manual for psychopharmacology—Revised. Rockville. NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, , MD 1976
   Google Scholar
• Bodlund O, Kullgren G, Ekselius L, Lindstrom E, von Knorring L. Axis V—Global Assessment of Functioning Scale. Evaluation of a self-report version. Acta Psychiatr Scand 1994; 90: 342–7
   PubMed Web of Science ®Google Scholar
• Ottosson H, Bodlund O, Ekselius L, Grann M, von Knorring L, Kullgren G, et al. DSM-IV and ICD-10 personality disorders: A comparison of a self-report questionnaire (DIP-Q) with a structured interview. Eur Psychiatry 1998; 13: 246–53
   PubMed Web of Science ®Google Scholar
• Lindstrom E, Lewander T, Malm U, Malt UF, Lublin H, Ahlfors UG. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nord J Psychiatry 2001; 55(Suppl 44)5–69
   PubMed Web of Science ®Google Scholar
• Eberhard, J, Lindström, E, Levander, S. Poor insight in schizophrenia is associated with low premorbid IQ and executive functioning, but not with failure to self-monitor. Submitted. 2008.
   Google Scholar
• Andreasen NC, Carpenter WT, Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441–9
   PubMed Web of Science ®Google Scholar
• van Os J, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, et al. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 2006; 113: 91–5
   PubMed Web of Science ®Google Scholar
• Lindström, E, Eberhard, J, Levander, S. Remission: Frequency, changes over time and association with illness, cognition and social outcome. Accepted 2007.
   Google Scholar
• Tuninger E, Levander S. Long-term outcome of depot neuroleptic maintenance treatment among chronic psychotic patients. Acta Psychiatr Scand 1997; 96: 347–53
   PubMedGoogle Scholar
• Wieselgren IM, Lindstrom LH. A prospective 1–5 year outcome study in first-admitted and readmitted schizophrenic patients; relationship to heredity, premorbid adjustment, duration of disease and education level at index admission and neuroleptic treatment. Acta Psychiat Scand 1996; 93: 9–19
   PubMed Web of Science ®Google Scholar
• Cullberg J, Levander S, Holmqvist R, Mattsson M, Wieselgren IM. One-year outcome in first episode psychosis patients in the Swedish Parachute project. Acta Psychiatr Scand 2002; 106: 276–85
   PubMed Web of Science ®Google Scholar
• Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Do patients with schizophrenia wish to be involved in decisions about their medical treatment?. Am J Psychiatry 2005; 162: 2382–4
   PubMed Web of Science ®Google Scholar
• Hamann J, Langer B, Winkler V, Busch R, Cohen R, Leucht S, et al. Shared decision making for in-patients with schizophrenia. Acta Psychiatr Scand 2006; 114: 265–73
   PubMed Web of Science ®Google Scholar
• Malm U, Ivarsson B, Allebeck P, Falloon IR. Integrated care in schizophrenia: A 2-year randomized controlled study of two community-based treatment programs. Acta Psychiatr Scand 2003; 107: 415–23
   PubMed Web of Science ®Google Scholar
• Vauth R, Kleim B, Wirtz M, Corrigan PW. Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia. Psychiatry Res 2007; 150: 71–80
   PubMed Web of Science ®Google Scholar
• Cronholm, B, von Knorring, L. Evaluation of mental health service programs. Swedish Medical Research Council Symposium Hässelby Castle, Stockholm;. 1983.
   Google Scholar